Table 3.
Patient outcomes.
Variable |
Median (range) or N (%) |
---|---|
Reason for discontinuation (n=12) | |
Disease progression | 9 (75%) |
Non-compliance | 1 (8.3%) |
Toxicity | 2 (17%) |
Best response (n=11) | |
Stable disease (SD) | 9 (82%) |
SD ≥90 days | 5 (45%) |
Progressive disease | 2 (18%) |
Duration of stable disease (n=9) | 119 (56–429) |